Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.
Antman EM, Cooper HA, Gibson CM, de Lemos JA, McCabe CH, Giugliano RP, Coussement P, Murphy S, Scherer J, Anderson K, Van de Werf F, Braunwald E; Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Antman EM, et al. Among authors: coussement p. Eur Heart J. 2002 Jun;23(12):928-33. doi: 10.1053/euhj.2001.2964. Eur Heart J. 2002. PMID: 12069446
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.
Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E. Antman EM, et al. Among authors: coussement p. Circulation. 1999 Jun 1;99(21):2720-32. doi: 10.1161/01.cir.99.21.2720. Circulation. 1999. PMID: 10351964 Clinical Trial.
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.
Antman EM, Gibson CM, de Lemos JA, Giugliano RP, McCabe CH, Coussement P, Menown I, Nienaber CA, Rehders TC, Frey MJ, Van der Wieken R, Andresen D, Scherer J, Anderson K, Van de Werf F, Braunwald E. Antman EM, et al. Among authors: coussement p. Eur Heart J. 2000 Dec;21(23):1944-53. doi: 10.1053/euhj.2000.2243. Eur Heart J. 2000. PMID: 11071800 Clinical Trial.
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
de Lemos JA, Gibson CM, Antman EM, Murphy SA, Morrow DA, Schuhwerk KC, Schweiger M, Coussement P, Van de Werf F, Braunwald E; TIMI 14 Investigators. de Lemos JA, et al. Among authors: coussement p. Am Heart J. 2001 Apr;141(4):592-8. doi: 10.1067/mhj.2001.113574. Am Heart J. 2001. PMID: 11275925
Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).
Mewton N, Cung TT, Morel O, Cayla G, Bonnefoy-Cudraz E, Rioufol G, Angoulvant D, Guerin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, Morice MC, Monassier JP, Ider O, Dubois-Randé JL, Unterseeh T, Lebreton H, Beard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Hansson MJ, Elmer E, Boussaha I, Jossan C, Torner A, Claeys M, Garcia-Dorado D, Ovize M; CIRCUS Study Investigators. Mewton N, et al. Among authors: coussement p. Am Heart J. 2015 Jun;169(6):758-766.e6. doi: 10.1016/j.ahj.2015.02.020. Epub 2015 Mar 13. Am Heart J. 2015. PMID: 26027612 Free article. Clinical Trial.
Vulnerability to cardiac arrest in patients with ST elevation myocardial infarction: Is it time or patient dependent? Results from a nationwide observational study.
Salah M, Gevaert S, Coussement P, Beauloye C, Sinnaeve PR, Convens C, De Raedt H, Dens J, Pourbaix S, Saenen J, Claeys MJ. Salah M, et al. Among authors: coussement p. Eur Heart J Acute Cardiovasc Care. 2020 Nov;9(4_suppl):S153-S160. doi: 10.1177/2048872619872127. Epub 2019 Aug 27. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 31452398
Adherence to quality indicators for ST-elevation myocardial infarction and its relation to mortality: a hospital network analysis from the Belgian STEMI database.
Bosmans S, Sluyts Y, Lysens de Oliveira E Silva-Van Acker J, Van Caenegem O, Sinnaeve PR, Dubois P, Vranckx P, Gevaert S, Coussement P, Beauloye C, Evrard P, Argacha JF, De Raedt H, Wouters K, Claeys MJ. Bosmans S, et al. Among authors: coussement p. Eur Heart J Qual Care Clin Outcomes. 2021 Oct 28;7(6):601-607. doi: 10.1093/ehjqcco/qcaa067. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 32941605
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
Rao SV, Kirsch B, Bhatt DL, Budaj A, Coppolecchia R, Eikelboom J, James SK, Jones WS, Merkely B, Keller L, Hermanides RS, Campo G, Ferreiro JL, Shibasaki T, Mundl H, Alexander JH; PACIFIC AMI Investigators. Rao SV, et al. Circulation. 2022 Oct 18;146(16):1196-1206. doi: 10.1161/CIRCULATIONAHA.122.061612. Epub 2022 Aug 27. Circulation. 2022. PMID: 36030390 Clinical Trial.
80 results